Triptolide (PG490)

Catalog No.S3604 Synonyms: NSC 163062

For research use only.

Triptolide (PG490, NSC 163062) is a diterpene triepoxide, immunosuppresive agent extracted from the Chinese herb Tripterygium wilfordii. It functions as a NF-κB inhibitor with dual actions by disruption of p65/CBP interaction and by reduction of p65 protein. Triptolide (PG490) abrogates the transactivation function of heat shock transcription factor 1 (HSF1). Triptolide inhibits MDM2 and induces apoptosis through a p53-independent pathway.

Triptolide (PG490) Chemical Structure

CAS No. 38748-32-2

Selleck's Triptolide (PG490) has been cited by 29 publications

Purity & Quality Control

Choose Selective ADC Cytotoxin Inhibitors

Biological Activity

Description Triptolide (PG490, NSC 163062) is a diterpene triepoxide, immunosuppresive agent extracted from the Chinese herb Tripterygium wilfordii. It functions as a NF-κB inhibitor with dual actions by disruption of p65/CBP interaction and by reduction of p65 protein. Triptolide (PG490) abrogates the transactivation function of heat shock transcription factor 1 (HSF1). Triptolide inhibits MDM2 and induces apoptosis through a p53-independent pathway.
Targets
NF-κB [1] HSF1 [1] MDM2 [1]
In vitro

Triptolide is a diterpene triepoxide with potent immunosuppressive and antiinflammatory properties. Triptolide is shown to inhibit the expression of IL-2 in activated T cells at the level of purine-box/nuclear factor and NF-κB mediated transcription activation. [1] Triptolide inhibits the proliferation and colony formation of tumor cells at extremely low concentrations (2–10 ng/mL). Triptolide has an inhibitory activity on breast, stomach and leukemia cell line HL-60 cells. Triptolide induces apoptosis in tumor cells by blocking NF-κB activation and sensitizing tumor cells for TNF-&alpha induced programmed cell death. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HT-29 MknCR5l1d3SxeHnjbZR6KGGpYXnud5Q> NYriSWFRS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUFRvMkmgZ4VtdHNuIFnDOVA:OC5yMEKx{txO Mn\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2N{C4OlQoRjJzNEewPFY1RC:jPh?=
HCT116 MUTDfZRwfG:6aXPpeJkh[WejaX7zeC=> MUTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gZ4VtdCC4aXHibYxqfHluIFnDOVA:OC5yMES3{txO MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{OTF{MUW0Okc,OzFzMkG1OFY9N2F-
SKOV3 MXHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2 NV\lWJdXPzJiaILz MWHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONT2[zJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCVUlKgZZN{[XluIFnDOVA:OC5yMEdOwG0> NETwXIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEizN|U1Oyd-MkC4N|M2PDN:L3G+
SKOV3 NWTDW29CS3m2b4TvfIlkcXS7IHHnZYlve3R? M174flczKGi{cx?= NV3uRY01S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hW0uRVkOgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGlEPTB;MD6wNFbPxE1? M{n3UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{e4O|A6Lz5{NEO3PFcxQTxxYU6=
SKOV3 MXjDfZRwfG:6aXOgZYN1cX[rdImgZYdicW6|dB?= NInufnM4OiCqcoO= M{LScWN6fG:2b4jpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLU3Y{KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkA4OiCqcoOgZpkhW1KEIHHzd4F6NCCLQ{WwQVAvODB5Mt88US=> MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDBzMUKyN{c,OjhyMUGyNlM9N2F-
KBM5 NEi4elVEgXSxdH;4bYNqfHliYXfhbY5{fA>? NFXpUnE4OiCqcoO= NXPtUplIS3m2b4TvfIlkcXS7IHHnZYlve3RiaX3heIlvcWJvcnXzbZN1[W62IHj1cYFvKEuETUWgZ4VtdHNiaHHyZo9zcW6pIFLjdk1C[mxiVEOxOWkhdXW2YX70JIFnfGW{IEeyJIhzeyCkeTDNWHMh[XO|YYmsJGlEPTB;MD6wNFg{|ryP NXT5e|hERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCxOFk3PjVpPkKwNVQ6PjZ3PD;hQi=>
SKOV3 MYXDfZRwfG:6aXPpeJkh[WejaX7zeC=> MWPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT29XOyClZXzsd{BjgSCVUlKgZZN{[XluIFnDOVA:OC5yMEpOwG0> MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
MDA-MB-468 NVLQbY1xS3m2b4TvfIlkcXS7IHHnZYlve3R? MmGxR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWRCNU2ELUS2PEBk\WyuczDifUBUWkJiYYPzZZktKEmFNUC9NE4xOc7:TR?= MmjSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
HCT116 MWPDfZRwfG:6aXPpeJkh[WejaX7zeC=> NEK5RnM4OiCqcoO= NFTtc4VEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJS1RzMU[gZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0xNjBzzszN MmjQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
SKOV3 M3rCcWN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MYO3NkBpenN? M17mbGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNMV1Z|IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE4xOc7:TR?= NH7rfHU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[zO|g4PCd-MUm2N|c5PzR:L3G+
KBM5 M1[3bGN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NFTpSow4OiCqcoO= NU[5OWFiS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hU0KPNTDj[YxteyCqYYLic5Jqdmdid3ns[EB1gXCnIFLjdk1C[mxiYX\0[ZIhPzJiaILzJIJ6KE2WUzDhd5NigSxiSVO1NF0xNjBzMEROwG0> M2ezS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUS5OlY2Lz5{MEG0PVY3PTxxYU6=
Rh30 NG\mcHVEgXSxdH;4bYNqfHliYXfhbY5{fA>? MkT0O|IhcHK| M{fnSmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHJpOzBiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlAyPM7:TR?= Mmr0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
A549 MkjORY51[WexbnnzeEBi[3Srdnn0fUBifA>? NXP5Oos3SW62YXfvcol{fCCjY4Tpeol1gSCjdDDoeY1idiCSQWKyJIV5eHKnc4Pl[EBqdiCqdX3hckBCPTR7IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhOmZvTFnHVmxQNU6KMj3pcoR2[2WmIF7Gb4FxeGGEIHHjeIl3[XSrb36gZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDJR|UxRTBwMEG0{txO NI\UZZM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{i5OVQ6Oid-MkO4PVU1QTJ:L3G+
SGC7901 NGDDRYhEgXSxdH;4bYNqfHliYXfhbY5{fA>? NXXKT4Q5PzJiaILz NELkT|dEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUT0N5OUCxJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC5yMUZOwG0> MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
MOLT4 MV3DfZRwfG:6aXPpeJkh[WejaX7zeC=> MkTRO|IhcHK| NH;jd4dEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOV0yWNDDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODF5zszN NX31PI9URGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2N|c5PzRpPkG5OlM4QDd2PD;hQi=>
A549 NHrBZnBEgXSxdH;4bYMh[WO2aY\peJkh[WejaX7zeC=> NWfCOGtKPzJiaILz M1PNVmN6fG:2b4jpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG1OFkh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIHPlcIwhfmmjYnnsbZR6KGGodHXyJFczKGi{czDifUBUWkJiYYPzZZktKEmFNUC9NE4xOTd3zszN M{HDZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6MEGxNlI{Lz5{OECxNVIzOzxxYU6=
SMMC7721 M2njNWN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MkK3O|IhcHK| NETDbHNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUVU2FN{eyNUBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTBwMEG4{txO Mm\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
PC3 MVfDfZRwfG:6aXOgZYN1cX[rdImgZYdicW6|dB?= M2PZRVczKGi{cx?= MoLCR5l1d3SxeHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiClZXzsJJZq[WKrbHn0fUBi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPUCuNFE5O87:TR?= MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDBzMUKyN{c,OjhyMUGyNlM9N2F-
MCF7 MnjpR5l1d3SxeHnjbZR6KGGpYXnud5Q> M{\hPVczKGi{cx?= NETZeWVEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE4xOToQvF2= M3rGb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
A549 MnTiR5l1d3SxeHnjbZR6KGGpYXnud5Q> NVnTOZplS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTV2OTDj[YxteyxiSVO1NF0xNjBzOd88US=> NV\1eZVsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0O|A5PjRpPkKxOFcxQDZ2PD;hQi=>
PC3 NGfJR5lEgXSxdH;4bYNqfHliYXfhbY5{fA>? NYridoJ1S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGK7IGPSRkBie3OjeTygTWM2OD1yLkCy{txO Mk\OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
Bel7402 MXjDfZRwfG:6aXPpeJkh[WejaX7zeC=> MmTYO|IhcHK| NEfsN4JEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBD\Wx5NECyJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC5yMt88US=> NUexOmJuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2N|c5PzRpPkG5OlM4QDd2PD;hQi=>
PC3 MorGRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dB?= M4DMPFczKGi{cx?= NHHMXHBCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDh[pRmeiB5MjDodpMh[nliU2LCJIF{e2G7LDDJR|UxRTBwMENOwG0> M{jXS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOEOzOVQ{Lz5{MEizN|U1OzxxYU6=
PC3 M2TR[WN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MV:3NkBpenN? MXLDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDQR|Mh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEmFNUC9NE4xOs7:TR?= M2m2blxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{e4O|A6Lz5{NEO3PFcxQTxxYU6=
PC3 MXXDfZRwfG:6aXPpeJkh[WejaX7zeC=> MUjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDQR|Mh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKHC{b3zp[oVz[XSrb36gZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygTWM2OD1yLkCy{txO MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR4N{G1PEc,OjV2NkexOVg9N2F-
786-O MljkR5l1d3SxeHnjbZR6KGGpYXnud5Q> NXPLe29qPzJiaILz NHnoTGFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckA4QDZvTzDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODJ{zszN Ml7GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
A549 MknXRY51[WexbnnzeEBi[3Srdnn0fUBifA>? NUXpXlg4SW62YXfvcol{fCCjY4Tpeol1gSCjdDDoeY1idiCSQWKyJIV5eHKnc4Pl[EBqdiCqdX3hckBCPTR7IHPlcIx{KGOxZYjwdoV{e2mwZzDURWNTOSCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHO3YoP0ZY5k\SCSLXnu[JVk\WRiSVytPEBxem:mdXP0bY9vKGK7IFXMTXNCNCCLQ{WwQVAvODJ|zszN MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzh7NUS5Nkc,OjN6OUW0PVI9N2F-
MDA-MB-231 MoLyR5l1d3SxeHnjbZR6KGGpYXnud5Q> NV\zUXBSPzJiaILz NHzKdldEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD6wNlTPxE1? MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
DU145 MknCR5l1d3SxeHnjbZR6KGGpYXnud5Q> MVS3NkBpenN? MW\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDEWVE1PSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFI1|ryP Mn;tQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
HO8910 NG\VcmhEgXSxdH;4bYNqfHliYXfhbY5{fA>? MoD4O|IhcHK| M1XwTWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhQQDlzMDDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODJ6zszN MoHnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
HCT15 M{\vemN6fG:2b4jpZ4l1gSCjZ3HpcpN1 M4jublczKGi{cx?= NW[2WVZTS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEOWMUWgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0xNjB{Od88US=> M3TnTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
A549 MU\Hdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbh?= Ml74S5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gRVU1QSClZXzsd{whUUN3ME2wMlA{|ryP NEe4SnQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEixOFM4PCd-Mki4NVQ{PzR:L3G+
32D NVPpXppTS3m2b4TvfIlkcXS7IHHnZYlve3R? MlraO|IhcHK| NHzpU5hEgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UA{OkRiY3XscJMhcGG{Yn;ybY5oKHerbHSgeJlx\SCEY4KtRYJtKGGodHXyJFczKGi{czDifUBOXFNiYYPzZZktKEmFNUC9NE4xOzMQvF2= M2WySFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUS5OlY2Lz5{MEG0PVY3PTxxYU6=
U251 M{DoSmN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NIjCNGFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBWOjVzIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDwdo9tcW[ncnH0bY9vKGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEmFNUC9NE4xOzQQvF2= MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR4N{G1PEc,OjV2NkexOVg9N2F-
32D NIezUHVEgXSxdH;4bYNqfHliYXfhbY5{fA>? MXq3NkBpenN? NVHhVmpuS3m2b4TvfIlkcXS7IHHnZYlve3RiaX3heIlvcWJvcnXzbZN1[W62IH3veZNmKDN{RDDj[YxteyCqYYLic5JqdmdiQnPyMWFjdCCWM{G1TUBufXSjboSgZYZ1\XJiN{KgbJJ{KGK7IF3UV{Bie3OjeTygTWM2OD1yLkCzOO69VQ>? MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODF2OU[2OUc,OjBzNEm2OlU9N2F-
PC3 M1;kRmN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NH;WVVk4OiCqcoO= M17aVmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFQ{|ryP MmO1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
KB NUnYXI0yS3m2b4TvfIlkcXS7IHHnZYlve3R? NYH3OpV3PzJiaILz MVrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDLRkBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTBwMESz{txO MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
HepG2 NFjWU|BEgXSxdH;4bYNqfHliYXfhbY5{fA>? NILwXo81QCCqcoO= MV\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDI[ZBIOiClZXzsd{Bi\nSncjC0PEBpenNiYomgXHRVKGG|c3H5MEBKSzVyPUCuNFQ{O87:TR?= Mnn0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB4MUOzN|UoRjNyNkGzN|M2RC:jPh?=
HeLa M{HnPGN6fG:2b4jpZ4l1gSCjZ3HpcpN1 M3fQdVczKGi{cx?= NUG1c212S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODR5zszN MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
U251 NWni[GhTS3m2b4TvfIlkcXS7IHHnZYlve3R? M3e0UlczKGi{cx?= NX7iTVAyS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hXTJ3MTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODR7zszN NGficG89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[zO|g4PCd-MUm2N|c5PzR:L3G+
K562 NV;qfFJtS3m2b4TvfIlkcXS7IHHnZYlve3R? M2fJ[FczKGi{cx?= MUTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDLOVYzKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD6wOe69VQ>? M4PIPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
NIH/3T3 M1\yWWN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NUPyZ2F7S3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVkmKL{PUN{Bk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiClZXzsJJZq[WKrbHn0fUwhUUN3ME2wMlA2|ryP NGj1RVY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyNVU1Pid-M{GxNlE2PDZ:L3G+
SW1116 MoHVR5l1d3SxeHnjbZR6KGGpYXnud5Q> M37CNlczKGi{cx?= NGXDW3dEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUXzFzMU[gZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0xNjB3Mt88US=> M3TNfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
A549 Mlr3R5l1d3SxeHnjbZR6KGGpYXnud5Q> NHW4NGw4OiCqcoO= Mn\pR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFU6|ryP NGPzOmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[zO|g4PCd-MUm2N|c5PzR:L3G+
HeLa NYP3Sm92S3m2b4TvfIlkcXS7IHHnZYlve3R? M1\WfmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gZ4VtdCC4aXHibYxqfHluIFnDOVA:OC5yOEhOwG0> NFzzcZk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyNVU1Pid-M{GxNlE2PDZ:L3G+
Jurkat NWnz[4tGS3m2b4TvfIlkcXS7IHHnZYlve3R? NFT2WIREgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBLfXKtYYSgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4h[2WubDD2bYFjcWyrdImsJGlEPTB;MD6xOO69VQ>? MoPHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzFzMkG1OFYoRjNzMUKxOVQ3RC:jPh?=
MKN28 MYHDfZRwfG:6aXPpeJkh[WejaX7zeC=> MkO2O|IhcHK| MkHtR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWtPOjhiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlLPxE1? MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
MDCK NWPFSpVVS3m2b4TvfIlkcXS7IHHnZYlve3R? MoTFR5l1d3SxeHnjbZR6KGGpYXnud5QhVUSFSzDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBk\WyuII\pZYJqdGm2eTygTWM2OD1zLkNOwG0> Mo\WQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzFzMkG1OFYoRjNzMUKxOVQ3RC:jPh?=
Pkd1-/- NV;yTIExUW6mdXP0bY9vKG:o Mo\0TY5lfWO2aX;uJI9nKGOnbHyg[5Jwf3SqIHHydoV{fCCrbjDtc5V{\SCSa3SxMU8uKGOnbHzzJIlvKHC{ZYPlcoNmKG:oIHPhcINqfW1? NV\m[5hYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUezOlA2OzRpPkG3N|YxPTN2PD;hQi=>
Pkd1-/- NXjINWxVUW6lcnXhd4UhcW5? NVnMXYpqOTByIH7N MlHsPVYhcHK| NInvfXFKdmO{ZXHz[UBqdiCyMkHDTXAwX0GIIHX4dJJme3Orb36gbY4hdW:3c3WgVItlOS1xLTDj[YxteyCjdDCxNFAhdk1iYX\0[ZIhQTZiaILzJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrcx?= Ml:yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd|NkC1N|QoRjF5M{[wOVM1RC:jPh?=
Pkd1+/- MYjJcoNz\WG|ZTDpci=> MmLrNVAxKG6P NVnjZ415UW6lcnXhd4UhcW5iUFOyJIRmeGWwZHXueEBk[WylaYXtJJJmdGWjc3WgbY4hdW:3c3WgVItlOStxLTDj[YxteyCjdDCxNFAhdk1? NIDYbFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{O2NFU{PCd-MUezOlA2OzR:L3G+
Pkd1-/- MWXJcoNz\WG|ZTDpci=> MVyxNFAhdk1? NHTEXoxKdmO{ZXHz[UBqdiCSQ{Kg[IVx\W6mZX70JINidGOrdX2gdoVt\WG|ZTDpckBud3W|ZTDQb4QyNS9vIHPlcIx{KGG2IEGwNEBvVQ>? MnXWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd|NkC1N|QoRjF5M{[wOVM1RC:jPh?=
Pkd1-/- MX3JcoNz\WG|ZTDpci=> M1\4T|UxKHWP M17ab2lv[3KnYYPlJIlvKGOjbHPpeY0hemWuZXHz[UBqdiCvb4Xz[UBRc2RzLT:tJINmdGy|IHH0JFUxKHWPIHnuJJBz\XOnbnPlJI9nKFK7UjDhcpRi\2:waYP0JIRidnS{b3zlcoU> M2LOWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5M{[wOVM1Lz5zN{O2NFU{PDxxYU6=
Pkd2+/- Moj4S5Jwf3SqIHnubIljcXSrb36gc4YhWEN{IHX4dJJme3OrbnegcY92e2V? MlrlNVAxKG6P NX;vXWhmOjRiaILz M4rjd2dzd3e2aDDpcohq[mm2aX;uJI9nKFCFMjDlfJBz\XO|aX7nJI1wfXOnIGDr[FIsNy1iY3XscJMh[XNiY3XscEBl\WG2aDDheEAyODBibl2gZYZ1\XJiMkSgbJJ{ NEHOOoc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{O2NFU{PCd-MUezOlA2OzR:L3G+
KBM5 MXnDfZRwfG:6aXPpeJkh[WejaX7zeC=> MVqwMlAxOSC2bzCxO{B2VQ>? M3PpUFczKGi{cx?= M3T2Z2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGtDVTViY3XscJMhcGG{Yn;ybY5oKHerbHSgeJlx\SCEY4KtRYJtKGG2IECuNFAyKHSxIEG3JJVOKGGodHXyJFczKGi{czDifUBOXFNiYYPzZZk> MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODF2OU[2OUc,OjBzNEm2OlU9N2F-
KBM5 MW\DfZRwfG:6aXPpeJkh[WejaX7zeC=> MXewMlAxOSC2bzCxO{B2VQ>? MnmwO|IhcHK| MmTRR5l1d3SxeHnjbZR6KGGpYXnud5QhcW2jdHnubYIuemW|aYP0ZY51KGi3bXHuJGtDVTViY3XscJMhcGG{Yn;ybY5oKEKlcj3BZowhXDNzNVmgcZV1[W62IHH0JFAvODBzIITvJFE4KHWPIHHmeIVzKDd{IHjyd{BjgSCPVGOgZZN{[Xl? MmO2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzNEm2OlUoRjJyMUS5OlY2RC:jPh?=
LNCAP NG[wNY9CdnSjZ3;ubZN1KGGldHn2bZR6KGG2 NGj0dpM2KHWP NXn4NGx[OjRiaILz MlK1RY51[WexbnnzeEBi[3Srdnn0fUBifCCDUjDpckBpfW2jbjDMUmNCWCClZXzsd{Bie3Onc4Pl[EBieyC|dYDwdoV{e2mxbjDv[kBFUFRvaX7keYNm\CC{ZXPldJRweiC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkh[XRiNTD1UUBi\nSncjCyOEBpenNiYomg[JVidCCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzl7NEezNUc,Ojd7OUS3N|E9N2F-
LNCAP MUnBcpRi\2:waYP0JIFkfGm4aYT5JIF1 NYjkfVNZPTByIH7N NIfubVQzPCCqcoO= MVPBcpRi\2:waYP0JIFkfGm4aYT5JIF1KEGUIHnuJIh2dWGwIFzOR2FRKGOnbHzzJIF{e2W|c3XkJIF{KHO3cIDy[ZN{cW:wIH;mJGRJXC2rbnT1Z4VlKHKnY3XweI9zKHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBifCB3MECgcm0h[W[2ZYKgNlQhcHK|IHL5JIR2[WxibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5 NWfRSWZrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke5PVQ4OzFpPkK3PVk1PzNzPD;hQi=>
HepG2 Mmn6RY51cXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4S= NI\zR48xNjJibXevb4c> M{LtOFE2KGSjeYO= M2HrcWFvfGm2dX3vdkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjldGczKGOnbHzzJJhmdm:pcnHmeIVlKGmwIFLhcIIw[yCwdXTlJI1wfXOnIHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiC2dX3vdkBoem:5dHigZZQhOC5{IH3nM4toNCCrcDDh[I1qdmm|dHXy[YQhd26lZTDkZYltgSCob4KgNVUh\GG7cx?= M4j1b|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyNkGzN|M2Lz5|ME[xN|M{PTxxYU6=
Assay
Methods Test Index PMID
Western blot c-Jun ; MDM2 ; p-AKT / AKT / p-Foxo3a / Foxo3a / p53 ; p-PI3K / PI3K / p85 / p110 22666381 27004407
Growth inhibition assay Cell viability 22666381
In vivo Triptolide synergizes with cyclosporin A in promoting graft survival in animal models and in suppression of graft versus host disease in allogeneic bone marrow transplants. In addition, it induces apoptosis in tumor cells and potentiates tumor necrosis factor (TNF-α) induction of apoptosis in part through the suppression of c-IAP2 and c-IAP1 induction. [1] [3] Triptolide treatment for 2–3 weeks inhibits the growth of xenografts formed by four different tumor cell lines (B16 melanoma, MDA-435 breast cancer, TSU bladder cancer, and MGC80-3 gastric carcinoma), indicating that TPL has a broad spectrum of activity against tumors that contain both wild-type and mutant forms of p53. In addition, Triptolide inhibits experimental metastasis of B16F10 cells to the lungs and spleens of mice. [2] Triptolide has in vitro and in vivo activities against mouse models of polycystic kidney disease. [4] LD50: Mice 0.83mg/kg (i.v.). [5]

Protocol (from reference)

Solubility (25°C)

In vitro

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
2% DMSO+30% PEG 300+2% Tween 80+ddH2O
For best results, use promptly after mixing.

3mg/mL

Chemical Information

Molecular Weight 360.4
Formula

C20H24O6

CAS No. 38748-32-2
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Triptolide (PG490) | Triptolide (PG490) supplier | purchase Triptolide (PG490) | Triptolide (PG490) cost | Triptolide (PG490) manufacturer | order Triptolide (PG490) | Triptolide (PG490) distributor